The Comparison Study

Type 2 Diabetes (T2D) prevents the body from maintaining healthy levels of glucose in the blood. T2D is a complex condition that can affect the entire body. Part 1 of the study focuses on how the drug is metabolised in the body of healthy participants with no history of diabetes.

The study drug is a powder that is taken orally after being mixed with a solution. The drug is designed to activate an enzyme that could reduce the complications caused by T2D. In this study, the powder form of the drug will be compared to a capsule form, in order to see whether the capsule is as effective as the powder.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!